Metastatic breast cancer patients with lung or liver metastases should be distinguished before being treated with fulvestrant August 2, 2019
Verzenio-Faslodex combo prolongs survival in advanced breast cancer, interim phase 3 data show August 2, 2019
Novartis Kisqali (ribociclib) significantly prolongs life in women with HR+/HER2- advanced breast cancer now in two distinct Phase III trials July 31, 2019
HER2 mutations correlate with clinicopathological features of breast cancer (Full article not available) July 19, 2019